St. Francis Cancer Center | St. Francis Cancer Center | Available Clinical Trials
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
421
page-template,page-template-full_width_inside,page-template-full_width_inside-php,page,page-id-421,page-child,parent-pageid-283,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.9,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Available Clinical Trials

Search Clinical Trials

To view available Clinical Trials, search using the fields below. For more information about an available trial, contact our Oncology Research Department at 864-603-6211.

Available Clinical Trials

Search by Type: or
Reset

Displaying All Clinical Trials (62)
A011401
Randomized Phase III Trial Evaluating the Role of Weight Loss …
A011502
Alliance A11502 - Aspirin in Preventing Recurrence of Cancer in Patients …
A021502
Alliance A021502 - Randomized Trial of Standard Chemotherapy Alone or …
A031102
A031102 – A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy …
A031501
A031501 - Phase III randomized “Adjuvant study of MK-3475 (pembrolizumab) …
A031704
Alliance A031704 - “PD-inhibitor (Nivolumab) and Ipilimumab followed by nivolumab …
A041501
A041501 - A Phase III Trial to Evaluate the Efficacy …
A041701
A041701 - A Randomized Phase II/III Study of Conventional Chemotherapy …
A041702
A041702 - A Randomized Phase III Study of Ibrutinib Plus …
A051301
A051301 - A randomized double-blind phase III study of ibrutinib …
A051701
A051701 - Randomized phase II/III study of venetoclax (ABT 199) …
A081105
Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo …
A151216
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST). …
A221505
A221505 - RT CHARM: Phase III Randomized Trial of Hypofractionated …
AGCT1531
AGCT1531: A Phase 3 Study of Active Surveillance for Low …
Apollomics APL 101-01
Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, …
BMS CA209-592
An Exploratory Study of the Biologic Effects and Biomarkers of …
BMS CA209-592
An Exploratory Study of the Biologic Effects and Biomarkers of …
BMS CA209-914
A Phase 3 Randomized Study Comparing Nivolumab and Ipilimumab Combination …
BMS CA209-914
A Phase 3 Randomized Study Comparing Nivolumab and Ipilimumab Combination …
CCTG MA.39
Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer …
Daiichi Sankyo DS8201-A-U303
A PHASE 3, MULTICENTER, RANDOMIZED, OPENLABEL, ACTIVE-CONTROLLED TRIAL OF DS-8201A, …
E4512
A Phase III Double-Blind Trial for Surgically Resected Early Stage …
EA1131
Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. …
EA3161
EA3161 - A Phase II/III Randomized Study of Maintenance Nivolumab …
EA4151
EA4151 - A Randomized Phase III Trial of Consolidation with …
EA6134
EA6134 - A Randomized Phase III Trial of Dabrafenib + …
EA8143
EA8143 – A Phase 3 RandOmized Study Comparing PERioperative Nivolumab …
EA9131
EA9131 - A Simplified Patient Care Strategy to Decrease Early …
EA9161
EA9161 - A Randomized Phase III Study of the Addition …
EAQ162CD
EAQ162CD - Longitudinal Assessment of Financial Burden in Patients with …
ECOG EA2182
EA2182, A Randomized Phase II Study of De-intensified Chemoradiation for …
Exact Sciences 2018-01
Blood Sample Collection to Evaluate Biomarkers in Subjects with Untreated …
Exact Sciences 2018-02
Blood Sample Collection to Evaluate Biomarkers in Subjects with Untreated …
Galera GTI 4419-301
ROMAN: Reduction in Oral Mucositis with Avasopasem Manganese (GC4419) – …
Galera GTI-4419-203
A Phase 2A Open-Label Trial of the Effects of Intravenous …
Genmab GCT1015-05
A Phase 1b/2 Open-Label Trial of Tisotumab Vedotin (HuMax®-TF-ADC) Monotherapy …
GIT 4419-203
  A Phase 2a Open-Label Trial of the Effects of Intravenous …
GOG 0263
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation …
Infinity IPI 549 02
A Phase 2, Multicenter, Randomized, Double-Blind, Active-Control Study to Evaluate …
Merck MK3475-667
An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) …
Merck MK3475-966
A Phase 3 Randomized, Double Blind Study of Pembrolizumab Plus …
NHLBI-MDS
The National Myelodysplastic Syndromes (MDS) Study
NRG BR003
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin …
NRG GY005
NRG GY005 - A Randomized Phase II/III study of the …
NRG-CC004
NRG-CC004 - Phase II Double Blind Dose Finding Trial of …
NRG-GI004 / SWOG-S1610
NRG-GI004/SWOG-S1610: Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A Randomized …
NRG-GU002
NRG-GU002 - Phase II-III Trial Of Adjuvant Radiotherapy and Androgen …
NRG-GU007
NRG-GU007, Randomized Phase II Trial of Niraparib with Standard Combination …
NRG-GY018
NRG-GY018 - A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab …
NRG-LU002
NRG-LU002 - Maintenance Systemic Therapy versus Consolidative Stereotactic Body Radiation …
NSABP B-51
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and …
PUMA NER-5201
AN OPEN-LABEL, PHASE 2 STUDY OF NERATINIB IN PATIENTS WITH …
QUILT 2.023
A PHASE 2, OPEN-LABEL, RANDOMIZED STUDY OF N-803, A FUSION …
QUILT 3.055
A Phase 2b, Single-Arm, Multicohort, Open-Label Study of ALT-803 in …
S1418
SWOG S1418 - A Randomized, Phase III Trial to Evaluate …
S1616
S1616 - A Phase II Randomized Study of Nivolumab (NSC-748726) …
S1801
S1801 - A Phase II Randomized Study of Adjuvant Versus …
S1815
S1815 - A Phase III Randomized Trial of Gemcitabine, Cisplatin, …
SWOG S1714
S1714 - A Prospective Observational Cohort Study to Develop a …
SWOG S1826
S1826 - A Phase III, Randomized Study of Nivolumab (Opdivo) …
Takeda Ponatinib-3001
A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus …